Federated Hermes’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Federated Hermes's LAB Position: Q1 2026 in Review
Federated Hermes sold out of Standard BioTools (LAB) in Q1 2026, closing a stake of 17,001 shares — an estimated $21.8K sold.
Federated Hermes first reported a position in LAB in Q3 2015 and held it in 18 quarters. The position peaked at $755K in Q4 2015. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Federated Hermes reported no remaining Standard BioTools position as of Q1 2026 after selling out during the quarter.
- Federated Hermes sold 17,001 Standard BioTools shares in Q1 2026, an estimated $21.8K.
- Federated Hermes first reported a position in Standard BioTools in Q3 2015 and held it in 18 quarters.
- Federated Hermes's Standard BioTools position peaked at $755K in Q4 2015.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.